A. Cell-specific expression of the Cd8a gene is controlled by stage-specific enhancer elements, of which five are known (E8I-E8V). Nuclear factors that bind to these regions include Ikaros 73, RUNX1 (runt-related transcription factor 1)95, 109, RUNX383, 87, 95, MAZR (MAZ-related factor)110 and STAT5 (signal transducer and activator of transcription 5)53. In contrast to Cd8 gene expression, tissue specific expression of the Cd4 gene is not accomplished by Cd4 enhancer elements (E4)111–113, but is mainly controlled by activation of a silencer element (S4) that is located in the first intron60, 61, 109, 114. Nuclear factors that bind to the CD4 silencer element include RUNX, MYB and HES195, 109, 115, 116. B. Changes in co-receptor transcription during positive selection and lineage choice according to the kinetic signalling model. CD8 expression on pre-selection double-positive (DP) thymocytes is driven in part by the E8III Cd8 enhancer, which is turned off by T-cell receptor (TCR)-mediated positive selection signalling20, 62. In CD4+CD8low intermediate thymocytes, persistent TCR-mediated positive selection signalling inhibits Cd8 gene expression and inhibits Cd4 silencer activity, so that intermediate cells differentiate into CD4+ T cells. However, cessation of TCR-mediated positive selection signalling in intermediate thymocytes results in re-initiation of Cd8 gene expression, at least in part, by induction of E8I Cd8 enhancer activity, which is responsive to interleukin-7 receptor (IL-7R) signalling53.